⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Atherosclerotic Cardiovascular Disease Market to Register Incremental Growth at a CAGR of 4.9% During the Forecast Period (2025–2034) | DelveInsight
globenewswire.com
AMGN
ARWR
IONS
NVS
NVO
MRK
LLY
REGN
ESPR
ALNY
VRTX
XBI
diaTribe Convenes International Consensus to Guide Diabetes Technology Use During Pregnancy
prnewswire.com
BIIB
AMGN
LLY
JNJ
PFE
MRK
BMY
GILD
REGN
AZN
ABBV
SNY
NVO
LULU
GOOG
MSFT
AMZN
META
TSLA
NVDA
XOM
CVX
KO
PEP
MCD
DIS
BA
CAT
GS
JPM
BAC
WFC
C
T
VZ
CMCSA
NFLX
ADBE
CRM
INTC
QCOM
AMD
CSCO
HON
GE
IBM
ORCL
SAP
ACN
MU
AMAT
LRCX
ADI
TXN
NXPI
MRVL
MCHP
PYPL
CMG
SBUX
NKE
HD
PG
UNH
ELV
CVS
CI
HCA
MCK
CAH
Peptide Therapeutics Market Trends and Global Forecasts to 2040 - Investments Exceeding $7 Billion from Public and Private Sectors Reflect Burgeoning Interest and Potential Returns
globenewswire.com
APLS
BLRX
LLY
NVO
TAK
Using Recombinant Insulin and Trypsin for Safer Vaccine Production, Upcoming Webinar Hosted by Xtalks
prnewswire.com
NVO
HCWC
Biomedical and ICT Convergence Market Research Report 2025-2030: Opportunities in Developing Connected Medical Devices, Enhancing Precision Medicine, and Improving Healthcare Delivery
globenewswire.com
ABT
AMGN
ADI
AZN
BIIB
BIO
XRAY
GEHC
GILD
HON
JNJ
MDLZ
MRK
NVS
NVO
NXPI
PFE
SNY
SWX
STM
TEI
TXN
TMO
ZBH
FMS
JBL
LMT
MDT
ON
PHI
SYK
WMT
Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand
globenewswire.com
LLY
NVO
Best Weight Loss Pills for 2026: FDA Approves First Oral GLP-1 and What It Means for Patients
accessnewswire.com
NVO
LLY
Cellarity Provides Strategic Priorities and Outlook for 2026
businesswire.com
NVO
Best Oral Peptides for Weight Loss: Injectable vs Sublingual vs Daily Pill – Direct Meds Consumer Analysis
globenewswire.com
NVO
Pioneering Scientist Behind Revolutionary Weight-Loss Drugs and Leading Mathematician Honored with 2026 King Faisal Prize
globenewswire.com
NVO